Herman GA, O'Brien MP, Forleo-Neto E, Sarkar N, et al. Efficacy and safety of a single dose of casirivimab and imdevimab for the
prevention of COVID-19 over an 8-month period: a randomised, double-blind,
placebo-controlled trial. Lancet Infect Dis 2022 Jul 5. pii: S1473-3099(22)00416.
PMID: 35803290